Last updated at 03 Nov 2025 06:57 AM
Director
DIN: 00669091
Neena Goel . is currently associated with 4 companies in various capacities such as Director, Partner and Individual Subscriber. They serve as a Director at ONCOCARE SCIENTIFICS PRIVATE LIMITED. and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00669091.Neena Goel . is currently involved in 3 different roles. Their most recent position is with NANDA TOWER OWNER'S ASSOCIATIONS PRIVATE LIMITED as a Individual Subscriber. The first company Neena Goel . was appointed to as a director was ONCOCARE SCIENTIFICS PRIVATE LIMITED.. Neena Goel . is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Neena Goel . is currently associated with 4 companies in various capacities such as Director, Partner and Individual Subscriber. They serve as a Director at ONCOCARE SCIENTIFICS PRIVATE LIMITED. and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00669091.Neena Goel . is currently involved in 3 different roles. Their most recent position is with NANDA TOWER OWNER'S ASSOCIATIONS PRIVATE LIMITED as a Individual Subscriber. The first company Neena Goel . was appointed to as a director was ONCOCARE SCIENTIFICS PRIVATE LIMITED.. Neena Goel . is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Female
India
Gain instant access to verified contact details.
Current Companies (3)
Current LLPs (1)
Past Companies (0)
4y 4m 2y 2m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ONCOCARE SCIENTIFICS PRIVATE LIMITED. | Director | 28-May-2004 |
| RASIKA ENTERPRISE PRIVATE LIMITED | Director | 10-Oct-2006 |
| NANDA TOWER OWNER'S ASSOCIATIONS PRIVATE LIMITED | Individual Subscriber | 19-Jun-2025 |